Skip to main content
. 2023 Mar 3;13:1063670. doi: 10.3389/fonc.2023.1063670

Table 1.

Tumor and patient characteristics at baseline.

Variable Value n %
Gender male 119 73.9
female 42 26.1
Age 65-74 years 96 59.6
75-84 years 59 36.7
≥ 85 years 6 3.7
ECOG 0 58 36.0
1 75 46.6
2 28 17.4
Localization (distance from incisors) Cervical (15 - 18 cm) 19 11.8
Upper thoracic (18 - 24 cm) 42 26.1
Middle thoracic (24 - 32 cm) 59 36.7
Lower thoracic (32 - approximate 40 cm) 41 25.5
cT-stage T1 6 3.7
T2 19 11.8
T3 101 62.7
T4 33 20.5
Tx 2 1.2
cN-stage N0 40 24.8
N+ 119 73.9
Nx 2 1.2
M-stage M0 161 100.0
M1 0 0
AJCC-stage 1 4 2.5
2 39 24.2
3 81 50.3
4a 34 21.1
NA 3 1.9
Grading G1 3 1.9
G2 92 57.1
G3 48 29.8
G4 0 0
Gx 18 11.2
Charlson Comorbidity Index ≤ 5 64 39.8
> 5 95 59.0
NA 2 1.2

Staging of esophageal carcinomas was based on the versions of the TNM classification (Union for International Cancer Control [UICC]) and the clinical stages of the American Joint Committee on Cancer (AJCC) that were current at the time of first diagnosis (i.e., 6th, 7th or 8th edition of the UICC-AJCC TNM classification).

ECOG, Eastern Cooperative Oncology Group; AJCC, American Joint Committee on Cancer.